Today's Peptide News — October 7, 2026

A legal analysis of the FDA's peptide compounding process lays out where things stand for six peptides: BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax. The Pharmacy Compounding Advisory Committee voted in favor of adding them to the 503A bulk drug substances list in July 2026, even though FDA staff had recommended against inclusion. The votes are advisory and do not by themselves change how the substances are treated.

FDA can accept the recommendation, decline it, attach conditions, ask for more information or simply take more time. If it moves forward, a proposed rule, a public comment period and a final rule would follow. There is no statutory deadline, and the article notes the precedent of ten other substances, where the proposed rule came in December 2016 and the final rule in February 2019. A long delay could affect pharmacies almost as much as a rejection, and a favorable vote does not automatically place a peptide in Category 1.

This is background rather than a new development today, but it remains the central regulatory question for several peptides covered on PeptideWiki, including MOTS-c, BPC-157 and TB-500.

Stanford Medicine researchers, working with colleagues at the Sanford Burnham Prebys Medical Discovery Institute, report in Science that blocking the protein 15-PGDH regrew cartilage in old mice. Levels of the protein roughly doubled in mouse knee cartilage with age, and a drug that inhibits it restored thicker, more functional cartilage.

The treatment also lowered the likelihood of osteoarthritis after ACL-like knee injuries, and cartilage samples from knee-replacement patients began forming new joint cartilage when exposed to the inhibitor. The regeneration appeared to come from existing cartilage cells shifting toward a younger state rather than from stem cells. The results come from mice and tissue samples, so human trials are still needed.

According to KFF Health News's October 6 morning briefing, New York Gov. Kathy Hochul declared a statewide health emergency over rising measles cases. Separately, Pennsylvania's measles cases have surpassed 1,000 in its largest outbreak in decades, with five deaths reported.

The briefing also notes that the CDC's overseas disease detection work is shrinking under the State Department's new foreign aid approach.

KFF Health News's October 6 briefing reports that Kenya has confirmed its first imported Ebola case, linked to travel from Congo. The same briefing mentions a suspected case of pneumonic plague in Siberia, for which President Trump offered U.S. help.

Details on the patient and the public health response were not included in the briefing summary, so this item should be checked against primary reporting before any follow-up.

A two-year trial of 493 adults with overweight or obesity found that diet sodas were about as effective as water for long-term weight loss, according to ScienceDaily's summary of the study published October 3.

The finding speaks to a long-running debate over whether non-sugar sweeteners undermine weight management, and is relevant context for readers following GLP-1 and other pharmacological approaches to obesity.